Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Francesca.Hutton@globaldata.com

  • Home
  • Author: Francesca.Hutton@globaldata.com

Regulated Asset Base model for financing of nuclear power plants may help arrest the waning investor interest in the nuclear industry in the UK, says GlobalData

Following the UK government’s announcement to consider using the Regulated Asset Base (RAB) financing model for nuclear power plants, after Hitachi’s decision to pull out from the Wylfa Newydd Nuclear Power Plant, Harminder Singh, Power Analyst at GlobalData, a leading data and analytics company, offers his views on the impact of this on the UK’s […]
Read more

Sainsbury’s vows to fight on, but ASDA merger looks doomed, says GlobalData

In response to the CMA’s provisional findings on the proposed ASDA/Sainsbury’s merger, Patrick O’Brien, UK Retail Research Director for GlobalData, a leading data and analytics company, offers his view: “The CMA’s provisional findings on the proposed merger of ASDA and Sainsbury’s have devastated any prospect of the merger going ahead. Rather than just point to a […]
Read more

The inequality in the provision of Employee Benefits throughout the UK SME landscape creates opportunities for insurers to grow, says GlobalData

The majority of UK SMEs are not offering income protection cover to their entire workforce, with many choosing to only offer protection to management or owners. Given this, insurers which are already providing cover in this space could capitalize by targeting certain industries to increase penetration to all employees by leveraging their existing relationships, according […]
Read more

AI in epidemiology could lead to more efficient identification of the source of foodborne illness, says GlobalData

Following the news that researchers at the University of Georgia developed an Artificial Intelligence (AI) process that can help identify the source of a Salmonella outbreak, Ana Fernandez Menjivar, Senior Epidemiologist at GlobalData, a leading data and analytics company, offers her view on the impact of this innovation: “As more machines are able to comb […]
Read more

Adoption of drones being held back by regulation, says GlobalData

The disruption caused at UK airports last Christmas brought the use of drones into the public eye, but adoption is actually being held back by regulation, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Drones – Thematic Research’ states that the market for the civilian use of drones, both as recreational […]
Read more

Stem cell therapy offers potential for thalassemia patients to have fewer blood transfusions, says GlobalData

The possibility of using hematopoietic stem cells to restore production of normal hemoglobin is being investigated as a potential strategy to reduce the number of blood transfusions for thalassemia patients. Magdalene Crabbe, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “In clinical trials, stem cells from the bone marrow of […]
Read more

UCB’s partnership with Epilepsy Society offers strategic advantage to further their position in epilepsy, says GlobalData

UCB’s £2.5 million genomic research program with Epilepsy Society has the potential to transform the diagnosis and treatment of epilepsy patients, says GlobalData, a leading data and analytics company. The program is expected to be pioneering for a number of reasons. Most important of which is the rich source of clinical data available from the […]
Read more

Over half of all UK bank customers prefer simple day-to-day balance alerts to sophisticated AI or robo assistance tools, says GlobalData

The majority of UK banking customers prefer day-to-day assistance with existing personal financial management (PFM) tasks like simple balance alerts, rather than more sophisticated financial planning tools such as robo-advisors or AI-driven virtual assistants, according to GlobalData, a leading data and analytics company. Image for publication: Click link for UK banking heat map The company’s […]
Read more

Alzheimer’s disease drug failures plague R&D in neurology, says GlobalData

Despite 2018’s successes in the neurology market, research and development (R&D) setbacks in the field of Alzheimer’s disease continue to disappoint, says GlobalData, a leading data and analytics company.  The Alzheimer’s disease market received major blows when several amyloid targeting β-secretase (BACE) inhibitors dropped out during the year. Merck & Co. terminated verubecestat due to […]
Read more

Female contraceptive market set to be worth $8.7bn by 2027 following the expected release of four new drug candidates, says GlobalData

Contraceptive market sales were estimated to be $6.3bn across the 8MM* in 2017, which is expected to grow to $8.2bn in 2027, at a compound annual growth rate of 2.7%, according to GlobalData, a leading data and analytics company. GlobalData’s report: ‘Contraceptives: Opportunity Analysis and Forecasts to 2027’ states that the launch of four novel contraceptive […]
Read more

Unilever’s acquisition of Graze necessary step to achieving leadership in direct to consumer space, says GlobalData

Following the news of Unilever’s acquisition of Graze, Ronan Stafford, Research Director at GlobalData, offers his view: “Direct to consumer brands have a big future ahead of them, and Unilever’s acquisition of Graze is a necessary step in helping it to achieve leadership in this space. “Last July Unilever stated that direct to consumer accounted […]
Read more

Australia leads FPSO deployments in Oceania by 2025, says GlobalData

Australia will account for all floating production, storage and offloading vessels (FPSOs) planned for deployment in Oceania during 2019–2025, according to GlobalData, a leading data and analytics company.   The company’s report: ‘Q1 2019 Global FPSO Industry Outlook – Australia Leads FPSO Deployments in Asia-Pacific’ reveals that, globally, 67 planned and announced FPSOs are expected […]
Read more
1 … 7 8 9 10 11 … 16